Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | yes | yes: 4 |
Pissara et al. | yes | yes: 20 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 7 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005634 | nucleus | 5 | 12 |
GO:0005654 | nucleoplasm | 2 | 2 |
GO:0032991 | protein-containing complex | 1 | 12 |
GO:0043226 | organelle | 2 | 12 |
GO:0043227 | membrane-bounded organelle | 3 | 12 |
GO:0043229 | intracellular organelle | 3 | 12 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 12 |
GO:0110165 | cellular anatomical entity | 1 | 12 |
GO:1990904 | ribonucleoprotein complex | 2 | 12 |
Related structures:
AlphaFold database: Q4QCG1
Term | Name | Level | Count |
---|---|---|---|
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 12 |
GO:0006396 | RNA processing | 6 | 12 |
GO:0006399 | tRNA metabolic process | 7 | 2 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 12 |
GO:0006807 | nitrogen compound metabolic process | 2 | 12 |
GO:0008033 | tRNA processing | 8 | 2 |
GO:0008152 | metabolic process | 1 | 12 |
GO:0009987 | cellular process | 1 | 12 |
GO:0016070 | RNA metabolic process | 5 | 12 |
GO:0034470 | ncRNA processing | 7 | 2 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 12 |
GO:0034660 | ncRNA metabolic process | 6 | 2 |
GO:0043170 | macromolecule metabolic process | 3 | 12 |
GO:0044237 | cellular metabolic process | 2 | 12 |
GO:0044238 | primary metabolic process | 2 | 12 |
GO:0046483 | heterocycle metabolic process | 3 | 12 |
GO:0071704 | organic substance metabolic process | 2 | 12 |
GO:0090304 | nucleic acid metabolic process | 4 | 12 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 12 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 12 |
GO:0003723 | RNA binding | 4 | 12 |
GO:0003729 | mRNA binding | 5 | 2 |
GO:0005488 | binding | 1 | 12 |
GO:0097159 | organic cyclic compound binding | 2 | 12 |
GO:1901363 | heterocyclic compound binding | 2 | 12 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 125 | 127 | PF00675 | 0.317 |
CLV_NRD_NRD_1 | 191 | 193 | PF00675 | 0.680 |
CLV_NRD_NRD_1 | 333 | 335 | PF00675 | 0.854 |
CLV_NRD_NRD_1 | 80 | 82 | PF00675 | 0.473 |
CLV_NRD_NRD_1 | 9 | 11 | PF00675 | 0.380 |
CLV_PCSK_KEX2_1 | 125 | 127 | PF00082 | 0.317 |
CLV_PCSK_KEX2_1 | 193 | 195 | PF00082 | 0.713 |
CLV_PCSK_KEX2_1 | 333 | 335 | PF00082 | 0.811 |
CLV_PCSK_KEX2_1 | 80 | 82 | PF00082 | 0.471 |
CLV_PCSK_KEX2_1 | 9 | 11 | PF00082 | 0.380 |
CLV_PCSK_PC1ET2_1 | 193 | 195 | PF00082 | 0.713 |
CLV_PCSK_SKI1_1 | 23 | 27 | PF00082 | 0.317 |
CLV_PCSK_SKI1_1 | 278 | 282 | PF00082 | 0.687 |
CLV_PCSK_SKI1_1 | 82 | 86 | PF00082 | 0.580 |
DOC_CKS1_1 | 210 | 215 | PF01111 | 0.726 |
DOC_MAPK_gen_1 | 140 | 149 | PF00069 | 0.528 |
DOC_MAPK_gen_1 | 7 | 14 | PF00069 | 0.414 |
DOC_MAPK_HePTP_8 | 137 | 149 | PF00069 | 0.603 |
DOC_MAPK_MEF2A_6 | 140 | 149 | PF00069 | 0.517 |
DOC_PP1_RVXF_1 | 8 | 15 | PF00149 | 0.517 |
DOC_USP7_MATH_1 | 103 | 107 | PF00917 | 0.544 |
DOC_USP7_MATH_1 | 136 | 140 | PF00917 | 0.578 |
DOC_USP7_MATH_1 | 216 | 220 | PF00917 | 0.515 |
DOC_USP7_MATH_1 | 63 | 67 | PF00917 | 0.570 |
DOC_WW_Pin1_4 | 209 | 214 | PF00397 | 0.665 |
LIG_14-3-3_CanoR_1 | 278 | 283 | PF00244 | 0.547 |
LIG_14-3-3_CanoR_1 | 49 | 54 | PF00244 | 0.528 |
LIG_APCC_ABBA_1 | 259 | 264 | PF00400 | 0.476 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.613 |
LIG_BIR_III_2 | 83 | 87 | PF00653 | 0.593 |
LIG_FHA_1 | 102 | 108 | PF00498 | 0.512 |
LIG_FHA_1 | 174 | 180 | PF00498 | 0.472 |
LIG_FHA_1 | 93 | 99 | PF00498 | 0.369 |
LIG_FHA_2 | 175 | 181 | PF00498 | 0.538 |
LIG_FHA_2 | 252 | 258 | PF00498 | 0.604 |
LIG_LIR_Apic_2 | 95 | 100 | PF02991 | 0.370 |
LIG_LIR_Gen_1 | 13 | 22 | PF02991 | 0.517 |
LIG_LIR_Gen_1 | 144 | 150 | PF02991 | 0.517 |
LIG_LIR_Gen_1 | 230 | 240 | PF02991 | 0.496 |
LIG_LIR_Gen_1 | 46 | 53 | PF02991 | 0.534 |
LIG_LIR_Nem_3 | 13 | 19 | PF02991 | 0.517 |
LIG_LIR_Nem_3 | 144 | 149 | PF02991 | 0.517 |
LIG_LIR_Nem_3 | 230 | 235 | PF02991 | 0.487 |
LIG_LIR_Nem_3 | 36 | 41 | PF02991 | 0.507 |
LIG_LIR_Nem_3 | 46 | 50 | PF02991 | 0.507 |
LIG_Pex14_1 | 124 | 128 | PF04695 | 0.517 |
LIG_SH2_CRK | 165 | 169 | PF00017 | 0.615 |
LIG_SH2_PTP2 | 97 | 100 | PF00017 | 0.517 |
LIG_SH2_SRC | 178 | 181 | PF00017 | 0.648 |
LIG_SH2_STAT5 | 127 | 130 | PF00017 | 0.517 |
LIG_SH2_STAT5 | 15 | 18 | PF00017 | 0.517 |
LIG_SH2_STAT5 | 178 | 181 | PF00017 | 0.488 |
LIG_SH2_STAT5 | 249 | 252 | PF00017 | 0.466 |
LIG_SH2_STAT5 | 97 | 100 | PF00017 | 0.517 |
LIG_SH3_3 | 156 | 162 | PF00018 | 0.580 |
LIG_SH3_3 | 207 | 213 | PF00018 | 0.684 |
LIG_SH3_3 | 247 | 253 | PF00018 | 0.475 |
LIG_TRAF2_1 | 240 | 243 | PF00917 | 0.505 |
LIG_TRAF2_1 | 254 | 257 | PF00917 | 0.495 |
LIG_WRC_WIRS_1 | 44 | 49 | PF05994 | 0.517 |
LIG_WW_1 | 162 | 165 | PF00397 | 0.524 |
MOD_CK1_1 | 274 | 280 | PF00069 | 0.647 |
MOD_CK1_1 | 88 | 94 | PF00069 | 0.502 |
MOD_CK2_1 | 174 | 180 | PF00069 | 0.527 |
MOD_CK2_1 | 251 | 257 | PF00069 | 0.610 |
MOD_Cter_Amidation | 331 | 334 | PF01082 | 0.855 |
MOD_GlcNHglycan | 114 | 117 | PF01048 | 0.381 |
MOD_GlcNHglycan | 170 | 173 | PF01048 | 0.603 |
MOD_GlcNHglycan | 206 | 209 | PF01048 | 0.802 |
MOD_GlcNHglycan | 223 | 226 | PF01048 | 0.533 |
MOD_GSK3_1 | 112 | 119 | PF00069 | 0.548 |
MOD_GSK3_1 | 217 | 224 | PF00069 | 0.495 |
MOD_GSK3_1 | 274 | 281 | PF00069 | 0.615 |
MOD_GSK3_1 | 88 | 95 | PF00069 | 0.474 |
MOD_N-GLC_1 | 217 | 222 | PF02516 | 0.539 |
MOD_NEK2_1 | 174 | 179 | PF00069 | 0.519 |
MOD_NEK2_1 | 26 | 31 | PF00069 | 0.603 |
MOD_NEK2_1 | 271 | 276 | PF00069 | 0.609 |
MOD_PIKK_1 | 185 | 191 | PF00454 | 0.718 |
MOD_PKA_2 | 221 | 227 | PF00069 | 0.504 |
MOD_Plk_1 | 217 | 223 | PF00069 | 0.523 |
MOD_Plk_1 | 296 | 302 | PF00069 | 0.560 |
MOD_Plk_1 | 92 | 98 | PF00069 | 0.522 |
MOD_Plk_4 | 116 | 122 | PF00069 | 0.603 |
MOD_Plk_4 | 141 | 147 | PF00069 | 0.516 |
MOD_Plk_4 | 174 | 180 | PF00069 | 0.505 |
MOD_Plk_4 | 296 | 302 | PF00069 | 0.508 |
MOD_Plk_4 | 92 | 98 | PF00069 | 0.451 |
MOD_ProDKin_1 | 209 | 215 | PF00069 | 0.644 |
MOD_SUMO_rev_2 | 230 | 238 | PF00179 | 0.549 |
MOD_SUMO_rev_2 | 293 | 300 | PF00179 | 0.544 |
MOD_SUMO_rev_2 | 52 | 60 | PF00179 | 0.558 |
TRG_ENDOCYTIC_2 | 165 | 168 | PF00928 | 0.552 |
TRG_ENDOCYTIC_2 | 249 | 252 | PF00928 | 0.480 |
TRG_ER_diArg_1 | 124 | 126 | PF00400 | 0.517 |
TRG_ER_diArg_1 | 192 | 195 | PF00400 | 0.695 |
TRG_ER_diArg_1 | 79 | 81 | PF00400 | 0.443 |
TRG_ER_diArg_1 | 8 | 10 | PF00400 | 0.580 |
TRG_ER_FFAT_2 | 108 | 119 | PF00635 | 0.622 |
TRG_NLS_MonoExtC_3 | 191 | 196 | PF00514 | 0.700 |
TRG_NLS_MonoExtN_4 | 190 | 196 | PF00514 | 0.696 |
TRG_Pf-PMV_PEXEL_1 | 58 | 62 | PF00026 | 0.365 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PDU8 | Leptomonas seymouri | 83% | 99% |
A0A0S4JIJ0 | Bodo saltans | 59% | 98% |
A0A1X0NXX1 | Trypanosomatidae | 64% | 100% |
A0A3Q8IB28 | Leishmania donovani | 97% | 100% |
A0A3R7NHU1 | Trypanosoma rangeli | 63% | 99% |
A4HBQ1 | Leishmania braziliensis | 91% | 100% |
A4HZ53 | Leishmania infantum | 97% | 100% |
D0A1Q9 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 63% | 100% |
E9AV21 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 95% | 100% |
P05455 | Homo sapiens | 28% | 83% |
P32067 | Mus musculus | 27% | 82% |
P38656 | Rattus norvegicus | 26% | 82% |
P40796 | Drosophila melanogaster | 26% | 87% |
V5DH11 | Trypanosoma cruzi | 61% | 100% |